Long-term clinical outcomes of endoscopic retrograde cholangiopancreatography for pancreatic duct stone treatment in children with chronic pancreatitis
PLOS One · 27.02.2026 · 21 (2) · e0336638
DOI: 10.1371/journal.pone.0336638 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 27.02.2026. Verfasst von Yong Lv und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Cholangiopancreatography, Endoscopic Retrograde, Pancreatitis, Chronic, Pancreatic Ducts, Calculi. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Evidence on long-term outcomes of endoscopic retrograde cholangiopancreatography (ERCP) for pancreatic duct stones (PDS) in children with chronic pancreatitis (CP) remains scarce. This study aimed to evaluate the long-term clinical outcomes of ERCP in this population.
Methods
A single-center retrospective cohort study was conducted on children with CP and PDS who underwent ERCP at our Hospital (2008.1.1–2024.12.31). Follow-up assessed stone clearance, complications, pain relief, pain type, growth, quality of life (QoL), and long-term complications.
Results
A total of 90 children with CP and PDS were enrolled in this single-center retrospective cohort study. ERCP achieved 72.1% complete stone clearance; overall complications were 9.6%. Among the 90 patients, 77 (85.6%) completed the full follow-up. Post-ERCP, all abdominal pain subtypes significantly decreased (P < 0.001), with 70.1% complete pain relief. Height and weight increased (P < 0.01); QoL (PedsQL™4.0) scores rose from 69 to 85 points (P < 0.001). Long-term complications included new diabetes (5.2%) and steatorrhea (5.2%); PDS recurrence was 7.8%.
Conclusion
ERCP is safe and effective for children with CP and PDS, significantly improving long-term pain, growth, and QoL, supporting its role as a first-line therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pediatric Surgery, West China Hospital, Sichuan University, Chengdu, China.
- Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China.
- West China School of Nursing, Sichuan University, Chengdu, China.
Zitieren
APA
Lv, Y., Yu, F., & Xiang, B. (2026). Long-term clinical outcomes of endoscopic retrograde cholangiopancreatography for pancreatic duct stone treatment in children with chronic pancreatitis. PLOS One, 21(2), e0336638. https://doi.org/10.1371/journal.pone.0336638
Vancouver
Lv Y, Yu F, Xiang B. Long-term clinical outcomes of endoscopic retrograde cholangiopancreatography for pancreatic duct stone treatment in children with chronic pancreatitis. PLOS One. 2026;21(2):e0336638. doi:10.1371/journal.pone.0336638
BibTeX
@article{Lv2026,
author = {Lv, Yong and Yu, Fangdi and Xiang, Bo},
title = {Long-term clinical outcomes of endoscopic retrograde cholangiopancreatography for pancreatic duct stone treatment in children with chronic pancreatitis},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {2},
pages = {e0336638},
doi = {10.1371/journal.pone.0336638}
}
EUVIMED